Sanofi launches inhaled insulin for diabetics

February 3, 2015 6:02 AM

3 0

Sanofi launches inhaled insulin for diabetics

PARIS (Reuters) - Sanofi launched an inhalable insulin in the United States on Tuesday in a potential boost for its flagging diabetes drug sales and for patient quality of life.

Developed by Mannkind Corp, Afrezza will be the only inhalable insulin on the U.S. market, where Sanofi competes with Eli Lilly and Novo Nordisk for sales of traditional injectable insulin.

Read more

To category page

Loading...